Brief: Precipio Conducts Iv-Cell Validation Trial With A Prominent Laboratory
May 6 (Reuters) - Precipio Inc PRPO.O :
* PRECIPIO CONDUCTS IV-CELL™ VALIDATION TRIAL WITH A
PROMINENT
LABORATORY
* PRECIPIO INC - IS IN PROCESS OF COMPLETING A TRIAL OF ITS
PROPRIETARY IV-CELL MEDIA WITH A LABORATORY WHOSE NAME IS
UNDISCLOSED AT THIS TIME
* PRECIPIO INC - PRECIPIO IS IN THE FINAL STAGES OF
NEGOTIATIONS
"WITH A LARGE-SCALE MANUFACTURER FOR THE MEDIA"
Source text for Eikon: ID:nGNX8qYfhb
Further company coverage: PRPO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precipio
See all newsCancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
Precipio Q1 revenue rises on higher pathology sales
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Brief: Precipio Identifies Unauthorized Access To Isolated Storage No Operational Impact
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers